Filing Details
- Accession Number:
- 0001104659-25-031297
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-02 18:06:41
- Reporting Period:
- 2025-04-01
- Filing Date:
- 2025-04-02
- Accepted Time:
- 2025-04-02 18:06:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1041024 | Rockwell Medical Inc. | RMTI | Pharmaceutical Preparations (2834) | 383317208 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1599219 | Mark Strobeck | C/O Rockwell Medical, Inc. 30142 Wixom Road Wixom MI 48393 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-04-01 | 6,926 | $1.08 | 124,678 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024 in multiple trades at prices ranging from $1.065 to $1.12. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
